- Home
- EPIX vs NCSM Comparison
EPIX vs NCSM Comparison
Compare EPIX & NCSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPIX
- NCSM
- Stock Information
- Founded
- EPIX 2009
- NCSM 2006
- Country
- EPIX Canada
- NCSM United States
- Employees
- EPIX N/A
- NCSM N/A
- Industry
- EPIX Biotechnology: Pharmaceutical Preparations
- NCSM Oilfield Services/Equipment
- Sector
- EPIX Health Care
- NCSM Energy
- Exchange
- EPIX Nasdaq
- NCSM Nasdaq
- Market Cap
- EPIX 65.3M
- NCSM 61.1M
- IPO Year
- EPIX N/A
- NCSM 2017
- Fundamental
- Price
- EPIX $1.72
- NCSM $31.44
- Analyst Decision
- EPIX Hold
- NCSM
- Analyst Count
- EPIX 3
- NCSM 0
- Target Price
- EPIX $2.00
- NCSM N/A
- AVG Volume (30 Days)
- EPIX 280.5K
- NCSM 9.4K
- Earning Date
- EPIX 05-08-2025
- NCSM 04-30-2025
- Dividend Yield
- EPIX N/A
- NCSM N/A
- EPS Growth
- EPIX N/A
- NCSM N/A
- EPS
- EPIX N/A
- NCSM 3.27
- Revenue
- EPIX N/A
- NCSM $168,704,000.00
- Revenue This Year
- EPIX N/A
- NCSM $7.03
- Revenue Next Year
- EPIX N/A
- NCSM $5.82
- P/E Ratio
- EPIX N/A
- NCSM $9.66
- Revenue Growth
- EPIX N/A
- NCSM 18.16
- 52 Week Low
- EPIX $1.40
- NCSM $15.90
- 52 Week High
- EPIX $7.88
- NCSM $38.95
- Technical
- Relative Strength Index (RSI)
- EPIX 52.43
- NCSM 52.40
- Support Level
- EPIX $1.67
- NCSM $29.15
- Resistance Level
- EPIX $1.79
- NCSM $32.71
- Average True Range (ATR)
- EPIX 0.08
- NCSM 1.84
- MACD
- EPIX -0.01
- NCSM 0.26
- Stochastic Oscillator
- EPIX 21.28
- NCSM 38.99
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.
About NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc provides products and support services that facilitate the optimization of oil and natural gas well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's primary offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. Geographically, majority of revenue is generated from United States.